SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-19-007370
Filing Date
2019-08-07
Accepted
2019-08-07 07:55:30
Documents
46
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 f6-k.htm 6-K 26113
2 ex-99d1.htm EX-99.1 787957
3 ex-99d2.htm EX-99.2 29322
  Complete submission text file 0001558370-19-007370.txt   2295943

Data Files

Seq Description Document Type Size
4 prqr-20190630.xml EX-101.INS 251907
5 prqr-20190630.xsd EX-101.SCH 32935
6 prqr-20190630_cal.xml EX-101.CAL 32135
7 prqr-20190630_def.xml EX-101.DEF 50650
8 prqr-20190630_lab.xml EX-101.LAB 220330
9 prqr-20190630_pre.xml EX-101.PRE 139733
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 191003857
SIC: 2834 Pharmaceutical Preparations